PSKY's Q2 Beat Doesn't Move the Stock Because the Market Hasn't Stopped Pricing a Disaster

The market is still pricing the old story. PSKY stock sits near $8.30, down roughly 37% year-to-date, trading at 0.74 times book value. The narrative hasn't budged: David Ellison's media megadeal is stalled, the antitrust trial is months away, and the $31.7 billion in corporate debt is a ticking clock.

The Q2 earnings report that came out today should have changed the frame. Instead, the stock barely moved from its recent lows, and for good reason. Investors know by now that a solid quarter from the standalone business doesn't erase the risk of a deal that could be dead by March 2027.

But the operating trajectory underneath the deal drama is getting cleaner in ways the tape has stopped registering. And that is where the inflection lives.

The numbers don't match the headline fear

Paramount Skydance reported Q2 revenue of $6.91 billion, ahead of the $6.88 billion consensus. Streaming revenue grew 9% year-over-year to $2.47 billion. The studio business, nearly doubled in scale since the Skydance merger closed last August, jumped 16% to $1.31 billion. TV media continued to bleed - down 9% to $3.13 billion - but cost cuts and programming discipline helped hold the margin line.

Paramount+ added 2 million subscribers in the quarter, bringing its global base to 81.6 million. Management called it the best retention quarter in the platform's history, anchored by the Yellowstone spinoff Dutton Ranch, the UFC, and FIFA World Cup coverage in Latin America.

More importantly, the company raised its full-year adjusted EBITDA guidance from a flat $3.8 billion to a range of $3.8 billion to $3.9 billion. Adjusted EBITDA - earnings before interest, taxes, depreciation, and amortization, a rough proxy for cash earnings - is the number that tells you whether cost discipline is actually translating into operating cash. The raise signals the $3 billion in Skydance integration savings are on track, with more than $2.5 billion expected to be eliminated by the end of 2026.

GAAP earnings, meanwhile, came in at 4 cents per share on $41 million of net income. That's thin, and the stock trades at a negative trailing P/E because the company is reporting accounting losses. But operating cash flow tells a different story: $650 million over the trailing twelve months against $210 million in capital expenditures. That's roughly $440 million in free cash flow - actual cash the business generated - while the income statement still shows a loss.

The cash conversion matters because it shows the cost-cutting machine is working even as the headlines scream about deal risk.

Why the tape didn't react

The WBD acquisition - a $110 billion all-cash deal announced in February at $31 per share - was supposed to close by September. That date has now been pushed to as late as June 2027, after a coalition of state attorneys general filed an antitrust challenge. The U.S. Justice Department cleared the deal. European regulators did too, requiring only that Paramount divest its stake in its European film distribution joint venture. The states' lawsuit goes to trial in March 2027.

A ticking fee of $0.25 per share per quarter kicks in for WBD shareholders if the deal slips further, which keeps both sides motivated. But the delay itself has been brutal for the stock, which hit a low near $8.17 in late July when the extension was announced.

So the Q2 beat didn't move the tape because the market has already decided: until the regulatory question is answered, PSKY is a binary event. Beat or miss - doesn't matter. The deal is the only thing that matters.

That's the old story. And it's the story that makes the setup work, because the numbers are improving while the price keeps acting like the company is a broken merger.

What gets better over the next 12 months

The case isn't that the WBD deal is a slam dunk. It isn't. The trial timeline introduces real uncertainty, and $31.7 billion of debt on a $9.4 billion market cap is a leverage profile that demands the deal close.

But the question worth asking is: if the deal doesn't close, or slips further, what's the standalone business actually worth?

DTC revenue grew 9% in Q2 and is expected to accelerate for the full year. The studio slate has nearly doubled. $2.5 billion-plus of cost savings are already in the bag. Free cash flow of $440 million is coming in while the stock trades below book value. The dividend - 6 consecutive years of payments, currently yielding 2.36% - hasn't been cut despite the leverage build-up and the accounting losses.

The Q3 revenue guidance of $6.95 billion to $7.15 billion is flat-to-up from Q2, with management expecting Paramount+ subscriber additions to be "flattish" quarter-over-quarter. That's not explosive growth. It's stable execution. But stable execution at this valuation, with the EBITDA guide already raised, is harder to dismiss than the tape suggests.

The market bar is near zero. The stock has been punished as if the WBD deal's delay means the entire company is going sideways. But the underlying cash-flow trajectory is moving the other direction.

The break condition

The thesis here is simple: the standalone business is improving while the market refuses to give it any credit because it's fixated on deal risk. The financial proof path is the raised EBITDA guide, the accelerating DTC and studio revenues, and the $440 million in free cash flow that the GAAP losses obscure.

The tripwire is straightforward. If the standalone business stops delivering - if Q3 or Q4 misses the raised EBITDA guide, if streaming revenue growth falls off, or if management cuts the dividend - then the operating case breaks alongside the deal case, and there's nothing left to anchor the stock.

Right now, the operating case is intact. The deal case is unresolved. The price acts like both are broken. That gap is the setup.